Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The database of the Danish Renal Cancer Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Positive Predictive Value of ICD-10 Diagnosis Codes for COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A validated register-based algorithm to identify patients diagnosed with recurrence of malignant melanoma in denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Robotic versus laparoscopic urological surgery: incidence of reoperation and complications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Astrid Christine Petersen
  • Mette Søgaard
  • Frank Mehnert
  • Erik Højkjær Larsen
  • Frede Donskov
  • Nessn H Azawi
  • Bjarne Kromann-Andersen
Vis graf over relationer

AIM OF THE DATABASE: The main purpose of the database of the Danish Renal Cancer Group (DaRenCaData) is to improve the quality of renal cancer treatment in Denmark and secondarily to conduct observational research.

STUDY POPULATION: DaRenCaData includes all Danish patients with a first-time diagnosis of renal cancer in the Danish National Pathology Registry since August 1, 2010.

MAIN VARIABLES: DaRenCaData holds data on demographic characteristics, treatments, and pathology collected through linkage to central registries and online registration of a few clinical key variables. Eight quality indicators have been selected for monitoring treatment quality and outcome after renal cancer.

DESCRIPTIVE DATA: The incidence of renal cancer in Denmark has increased from 12.7 per 100,000 population-years in 2010-2011 to 15.9 per 100,000 population-years in 2014-2015. A total of 3,977 Danish patients with renal cancer have been enrolled in the database in the period August 1, 2010-July 31, 2015. The completeness of data registration has increased substantially since the first years of the database. A tendency toward smaller and less advanced tumors, less invasive surgery, and a shorter hospital stay was observed, while the postoperative morbidity and mortality remained stable. Concurrently, the 1-year survival has improved and was 84.1% in 2014-2015.

CONCLUSION: DaRenCaData provides valuable information on quality of and outcome after renal cancer treatment. Efforts to improve collection and registration of data are ongoing.

OriginalsprogEngelsk
TidsskriftClinical Epidemiology
Vol/bind8
Sider (fra-til)725-729
Antal sider5
ISSN1179-1349
DOI
StatusUdgivet - 16 okt. 2016

ID: 49269865